Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization
- PMID: 2139097
- PMCID: PMC2187835
- DOI: 10.1084/jem.171.4.1057
Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization
Abstract
Sensitization of C57BL/6 (B6, H-2b) splenocytes against normal BALB/c (H-2d) leukocytes (B6 a/BALB) in bulk MLC induced CTL reactive against the syngeneic (H-2b) nonimmunogenic lymphoma PIR-2, in addition to the CTL directed against the corresponding (H-2d) allotargets. However, MLC-derived lymphocytes did not directly exhibit anti-PIR-2 cytotoxicity in spite of the high anti-PIR-2 CTL frequency (up to 1/20) among them, as demonstrated by the limiting dilution culture (LDC) technique. The present study was undertaken to resolve this contradiction. We found that anti-PIR-2 cytotoxicity could be detected only when B6 a/BALB MLC-derived responding cells were plated in LDC at low numbers (less than 200) of cells/well. In contrast, increasing the number of the plated cells to 500-5,000 resulted in a gradual decrease in the percentage of wells cytotoxically reactive against PIR-2, whereas the percentage of wells exhibiting cytotoxicity against the allotargets remained unchanged (100%). This decrease of anti-PIR-2 cytotoxicity in LDC and the lack of anti-PIR-2 reactivity among MLC-derived lymphocytes were shown by mixing experiments to result from the activity of radioresistant Thy-1+, Lyt-2+, L3T4- suppressor cells, blocking the anti-PIR-2 cytotoxicity at the effector phase. The suppression was specific as indicated by the following observations: (a) freshly obtained B6 splenocytes, cultured unsensitized B6 splenocytes, mitogen-induced B6 lymphoblasts, B6 LAK cells, or B6 a/B6 MLC-derived lymphocytes were not suppressive; (b) anti-PIR-2 cytotoxicity elicited in B6 a/BALB LDC was suppressed only by lymphocytes derived from B6 a/BALB MLC and not from B6 a/C3H (H-2k) MLC; and (c) B6 a/BALB MLC-induced suppressor cells could be adsorbed on monolayers of BALB/c but not of C3H lymphoblasts. Since both syngeneic tumor and allogeneic target cells were lysed by the same clonal cell population but only the antisyngeneic activity was suppressed, we suggest that a single CTL can exhibit two cytotoxic activities that are differentially affected by the described suppressor cells. This mode of suppression may play a role in controlling autoimmune reactivity.
Similar articles
-
Allosensitization in IL-2-containing limiting dilution cultures generates cytotoxic T lymphocytes (CTL) rather than LAK cells reactive with a syngeneic nonimmunogenic murine tumor.Immunol Lett. 1989 Jan 15;20(1):53-8. doi: 10.1016/0165-2478(89)90068-0. Immunol Lett. 1989. PMID: 2785493
-
In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization.Cancer Immunol Immunother. 1984;17(2):117-23. doi: 10.1007/BF00200047. Cancer Immunol Immunother. 1984. PMID: 6235909 Free PMC article.
-
Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.J Immunol. 1984 Jun;132(6):3218-25. J Immunol. 1984. PMID: 6202778
-
Blocking of effector cell cytotoxicity and T-cell proliferation by Lyt antisera.Immunol Rev. 1982;68:117-34. doi: 10.1111/j.1600-065x.1982.tb01062.x. Immunol Rev. 1982. PMID: 6757106 Review. No abstract available.
-
Selective effects of Adriamycin on murine host defense systems.Immunol Rev. 1982;65:55-78. doi: 10.1111/j.1600-065x.1982.tb00427.x. Immunol Rev. 1982. PMID: 6811413 Review. No abstract available.
Cited by
-
The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.Immunology. 1991 Feb;72(2):213-8. Immunology. 1991. PMID: 1901830 Free PMC article.
-
Chemo-immunotherapy of murine solid tumors: enhanced therapeutic effects by interleukin-2 combined with interferon alpha and the role of specific T cells.Cancer Immunol Immunother. 1992;35(1):63-8. doi: 10.1007/BF01741057. Cancer Immunol Immunother. 1992. PMID: 1611625 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous